![Sara Thuresson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sara Thuresson
Nessuna posizione attualmente
Profilo
Sara Thuresson worked as Director-Clinical Operations at Oncopeptides AB. From 2021 to 2026, Ms. Thuresson worked as Head-Clinical Operations at Guard Therapeutics International AB. Ms. Thuresson completed undergraduate studies at the University of Uppsala and graduate studies at Karolinska Institutet.
Precedenti posizioni note di Sara Thuresson
| Società | Posizione | Fine |
|---|---|---|
| DISRUPTIVE PHARMA AB | Direttore Tecnico/Scientifico/R&S | 30/04/2026 |
| ONCOPEPTIDES AB | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Sara Thuresson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
6
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Karolinska Institutet
 Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
